Differential localization of autolyzed calpains 1 and 2 in slow and fast skeletal muscles in the early phase of atrophy

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 5, 2007, Pages

  Vermaelen, Marianne ^a,b   Sirvent, Pascal ^a,b   Raynaud, Fabrice ^c   Astier, Catherine ^b   Mercier, Jacques ^a,b   Lacampagne, Alain ^a,b   Cazorla, Olivier ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c CNRS   (France)

Author keywords

Ca2+ dependent proteases; Immobilization; Skeletal muscle; Soluble and particulate fractions; Wasting

Indexed keywords

CALPAIN; CALPAIN I; CALPAIN II; CASPASE 3; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOLYSIS; CONTROLLED STUDY; FAST MUSCLE; IMMOBILIZATION; MUSCLE ATROPHY; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SKELETAL MUSCLE; SLOW MUSCLE; SOLEUS MUSCLE; WISTAR RAT; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; ENZYME ACTIVATION; ENZYMOLOGY; FAST MUSCLE FIBER; MALE; METABOLISM; MUSCLE CELL; MUSCLE FIBRIL; PATHOLOGY; PHENOTYPE; SLOW MUSCLE FIBER; TIME;

RATTUS;

ANIMALS; AUTOLYSIS; CALPAIN; CASPASE 3; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HINDLIMB SUSPENSION; MALE; MUSCLE FIBERS; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOFIBRILS; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, WISTAR; TIME FACTORS; UBIQUITIN;

EID: 34250678518     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00398.2006     Document Type: Article

References (51)

1. Baldwin KM, Haddad F. Skeletal muscle plasticity: cellular and molecular responses to altered physical activity paradigms. Am J Phys Med Rehabil 81: S40-S51, 2002.
2. Bartoli M, Richard I. Calpains in muscle wasting. Int J Biochem Cell Biol 37: 2115-2133, 2005.
3. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
4. Booth FW, Kelso JR. Production of rat muscle atrophy by cast fixation. J Appl Physiol 34: 404-406, 1973.
5. Burkard N, Becher J, Heindl C, Neyses L, Schuh K, Ritter O. Targeted proteolysis sustains calcineurin activation. Circulation 111: 1045-1053, 2005.
6. Carafoli E, Molinari M. Calpain: a protease in search of a function? Biochem Biophys Res Commun 247: 193-203, 1998.
7. Chockalingam PS, Cholera R, Oak SA, Zheng Y, Jarrett HW, Thomason DB. Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy. Am J Physiol Cell Physiol 283: C500-C511, 2002.
8. 2+-dependent proteinases (mu-calpain and m-calpain). J Biol Chem 264: 10096-10103, 1989.
9. Desplanches D, Mayet MH, Sempore B, Flandrois R. Structural and functional responses to prolonged hindlimb suspension in rat muscle. J Appl Physiol 63: 558-563, 1987.
10. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 113: 115-123, 2004.
11. Ebisui C, Tsujinaka T, Morimoto T, Fujita J, Ogawa A, Ishidoh K, Kominami E, Tanaka K, Monden M. Changes of proteasomes and cathepsins activities and their expression during differentiation of C2C12 myoblasts. J Biochem (Tokyo) 117: 1088-1094, 1995.
12. Enns DL, Belcastro AN. Early activation and redistribution of calpain activity in skeletal muscle during hindlimb unweighting and reweighting. Can J Physiol Pharmacol 84: 601-609, 2006.
13. Falduto MT, Czerwinski SM, Hickson RC. Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers. J Appl Physiol 69: 1058-1062, 1990.
14. Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 290: R1589-R1597, 2006.
15. Fraysse B, Desaphy JF, Pierno S, De Luca A, Liantonio A, Mitolo CI, Camerino DC. Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle. FASEB J 17: 1916-1918, 2003.
16. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 83: 731-801, 2003.
17. Grossman EJ, Roy RR, Talmadge RJ, Zhong H, Edgerton VR. Effects of inactivity on myosin heavy chain composition and size of rat soleus fibers. Muscle Nerve 21: 375-389, 1998.
18. Haddad F, Roy RR, Zhong H, Edgerton VR, Baldwin KM. Atrophy responses to muscle inactivity. II. Molecular markers of protein deficits. J Appl Physiol 95: 791-802, 2003.
19. Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem 274: 787-794, 1999.
20. Hong DH, Forsberg NE. Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures. Mol Cell Endocrinol 108: 199-209, 1995.
21. Huang J, Forsberg NE. Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci USA 95: 12100-12105, 1998.
22. Ikemoto M, Nikawa T, Takeda S, Watanabe C, Kitano T, Baldwin KM, Izumi R, Nonaka I, Towatari T, Teshima S, Rokutan K, Kishi K. Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J 15: 1279-1281, 2001.
23. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287: C834-C843, 2004.
24. Jakubiec-Puka A, Kordowska J, Catani C, Carraro U. Myosin heavy chain isoform composition in striated muscle after denervation and self-reinnervation. Eur J Biochem 193: 623-628, 1990.
25. Krawiec BJ, Frost RA, Vary TC, Jefferson LS, Lang CH. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289: E969-E980, 2005.
26. Kulkarni S, Goll DE, Fox JE. Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J Biol Chem 277: 24435-24441, 2002.
27. 2+-dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle. Anat Rec 232: 60-77, 1992.
28. Lebart MC, Mejean C, Casanova D, Audemard E, Derancourt J, Roustan C, Benyamin Y. Characterization of the actin binding site on smooth muscle filamin. J Biol Chem 269: 4279-4284, 1994.
29. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129: 227S-237S, 1999.
30. Marzia M, Chiusaroli R, Neff L, Kim NY, Chishti AH, Baron R, Horne WC. Calpain is required for normal osteoclast function and is down-regulated by calcitonin. J Biol Chem 281: 9745-9754, 2006.
31. 2+-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form. J Biol Chem 269: 27992-27995, 1994.
32. Morris CA, Morris LD, Kennedy AR, Sweeney HL. Attenuation of skeletal muscle atrophy via protease inhibition. J Appl Physiol 99: 1719-1727, 2005.
33. Munoz KA, Satarug S, Tischler ME. Time course of the response of myofibrillar and sarcoplasmic protein metabolism to unweighting of the soleus muscle. Metabolism 42: 1006-1012, 1993.
34. Murphy RM, Snow RJ, Lamb GD. μ-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans. Am J Physiol Cell Physiol 290: C116-C122, 2006.
35. 2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle. J Physiol 576: 595-612, 2006.
36. Onji T, Takagi M, Shibata N. Calpain abolishes the effect of filamin on the actomyosin system in platelets. Biochim Biophys Acta 912: 283-286, 1987.
37. Raynaud F, Carnac G, Marcilhac A, Benyamin Y. m-Calpain implication in cell cycle during muscle precursor cell activation. Exp Cell Res 298: 48-57, 2004.
38. Raynaud F, Fernandez E, Coulis G, Aubry L, Vignon X, Bleimling N, Gautel M, Benyamin Y, Ouali A. Calpain 1-titin interactions concentrate calpain 1 in the Z-band edges and in the N2-line region within the skeletal myofibril. FEBS J 272: 2578-2590, 2005.
39. Royuela M, Chazalette D, Rivier F, Hugon G, Paniagua R, Guerlavais V, Fehrentz JA, Martinez J, Mornet D. Dystrophin and dystrophin-associated protein in muscles and nerves from monkey. Eur J Histochem 47: 29-38, 2003.
40. Saito K, Elce JS, Hamos JE, Nixon RA. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90: 2628-2632, 1993.
41. Schiaffino S, Serrano A. Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol Sci 23: 569-575, 2002.
42. Srere PA Citrate synthase: [EC 4.1.3.7. citrate oxaloacetate-lyase (CoA-acetylating)]. In: Methods in Enzymology. Academic, 1969, p. 3-11.
43. Sultan KR, Dittrich BT, Leisner E, Paul N, Pette D. Fiber type-specific expression of major proteolytic systems in fast- to slow-transforming rabbit muscle. Am J Physiol Cell Physiol 280: C239-C247, 2001.
44. 2+ ions. J Biochem (Tokyo) 90: 275-278, 1981.
45. 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 316: 65-72, 1996.
46. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337-2340, 1993.
47. Tamada Y, Nakajima E, Nakajima T, Shearer TR, Azuma M. Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia. Brain Res 1050: 148-155, 2005.
48. Tidball JG, Spencer MJ. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 545: 819-828, 2002.
49. Vermaelen M, Marini JF, Chopard A, Benyamin Y, Mercier J, Astier C. Ubiquitin targeting of rat muscle proteins during short periods of unloading. Acta Physiol Scand 185: 33-40, 2005.
50. 2+-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97: 1610-1617, 1996.
51. Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147: 4160-4168, 2006.